Results for this period
Full year1 March 2025–28 February 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Fluctuations in orders for new products, a slowdown in large orders, sluggish orders for pharmaceuticals and cosmetics at the French subsidiary, and inflation-driven increases in raw material costs, personnel expenses and various other expenses. Net income increased due to the recognition of a ¥284 million gain on the sale of non-current assets.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2025–28 February 2026 |
| Net Sales | ¥16,643,028 thousand (YoY -5.6%) |
| Operating profit | ¥180,124 thousand (YoY -63.2%) |
| Ordinary income | ¥151,985 thousand (YoY -58.6%) |
| Profit attributable to owners of the parent | ¥335,394 thousand (YoY +55.1%) |
| Net income per share | ¥162.00 |
| Equity ratio | End of the current fiscal period 24.2 / End of previous period 22.5 |
| Total assets | ¥17,566,610 thousand |
| Net assets | ¥4,244,033 thousand |
| Cash flows from operating activities | ¥140,192 thousand |
| Cash flows from investing activities | ¥118,675 thousand |
| Cash flows from financing activities | ¥-179,282 thousand |
| Cash and cash equivalents at end of period | ¥1,080,500 thousand |
| Full-year earnings forecast | Net Sales ¥18,361 million (YoY +10.3%) / Operating profit ¥394 million / Ordinary income ¥275 million / Net income ¥187 million |
| Annual Dividend Forecast | ¥20 per share → ¥30 per share（+50.0%） |
| Segment revenue | Japan ¥11,789,799 thousand (YoY -5.2%), France ¥5,043,483 thousand (YoY -4.2%) |
| Segment profit | Japan ¥281,224 thousand (YoY -49.3%), France ¥-82,615 thousand |
| Regional sales | ¥11,789,799 thousand (YoY -5.2%), ¥5,043,483 thousand (YoY -4.2%) |
| Depreciation and amortization | ¥935,520 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥284,187 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥7,104 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Material subsequent events | On 25 March 2026, the Company acquired land measuring 4,927.82 square metres and a building measuring 1,424.30 square metres in Komoro, Nagano Prefecture, for ¥655.160 million. The impact on results for the fiscal year ending February 2027 is immaterial and has been incorporated into the earnings forecasts. |
| Factors Behind Changes in Business Performance | Fluctuations in orders for new products, a slowdown in large orders, sluggish orders for pharmaceuticals and cosmetics at the French subsidiary, and inflation-driven increases in raw material costs, personnel expenses and various other expenses. Net income increased due to the recognition of a ¥284 million gain on the sale of non-current assets. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to fluctuations in orders for new products, a slowdown in large orders, and sluggish growth in orders for pharmaceuticals and cosmetics at the French subsidiary, as well as inflation-driven increases in raw material costs, personnel expenses, subcontracting costs and various other expenses. The increase in net income was attributed to the recognition of a ¥284 million gain on the sale of non-current assets.